1. Ahmed, A., and P. B. Marshall: Relationship between anti-acetylcholine and anti-tremorine activity in antiparkinsonsian and related drugs. Brit. J. Pharmacol. 18, 247?254 (1962).
2. Bein, H. J., u. J. Tripod: Experimentelles Wirkungsspektrum von Aturban®, einer neuen synthetischen Verbindung zur Behandlung extrapyramidaler Störungen. Schweiz. med. Wschr. 88, 1160?1164 (1958).
3. Boissier, J. R., et P. Simon: Activité anticataleptique expérimentale de quelques antiparkinsoniens. C. R. Soc. Biol. (Paris) 158, 2025?2028 (1964).
4. Bovet, D., and V. G. Longo: The action on nicotine-induced tremors of substances effective in Parkinsonism. J. Pharmacol. exp. Ther. 102, 22?30 (1951).
5. Bijlsma, U. G., A. F. Harms, A. B. H. Funcke, H. M. Tersteege, and W. Th. Nauta: The pharmacology of ?-dimethylaminoethyl-2-methylbenzhydrylether hydrochloride (BS 5930). Arch. int. Pharmacodyn. 106, 332?369 (1956).